The comparative safety of first-line conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study

30/01/2020
30/01/2020
EU PAS number:
EUPAS33214
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

THIN, SIDIAP

Data sources (types)

Administrative healthcare records (e.g., claims)
Drug dispensing/prescription data
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.